Yuki Ishii - Concepedia

Author

Yuki Ishii

Saitama Cancer Center ORCID

Also Known As

Y Ishii, Y. Ishii, Yuki Ishii

Publications

865

Citations

H-Index

Concepts

All Affiliations

Saitama Cancer Center Shimane University Icahn School of Medicine at Mount Sinai University of Tsukuba University College London

About

Yuki Ishii is an author at Saitama Cancer Center specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	406
2	Cell Biology	10	10	387
3	Cellular Physiology	2	2	124
4	Immunology	2	2	83
5	Pathology	1	1	19

Yuki Ishii

Publications

791

Citations

H-Index

Page 1

	Year	Citations
FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination Elaine Guo, Yuki Ishii, J. Mueller, Proceedings of the National Academy of Sciences	2020	98
Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones. Yuki Ishii, Yûko Hori, Shingo Sakai, PubMed Cell DivisionCell ControlMedicineApoptosisCytokinin Nucleosides	2002	91
Cyclin D1 Overexpression and Response to Bortezomib Treatment in a Breast Cancer Model Yuki Ishii, Andreja Pirkmaier, James V. Alvarez, JNCI Journal of the National Cancer Institute	2006	65
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones Yuki Ishii, Hiromasa Kiyota, Shingo Sakai, Leukemia Developmental BiologyGeneticsMyelopoiesisGene ExpressionMedicine	2004	60
Tamoxifen Stimulates the Growth of Cyclin D1–Overexpressing Breast Cancer Cells by Promoting the Activation of Signal Transducer and Activator of Transcription 3 Yuki Ishii, Samuel Waxman, Doris Germain Cancer Research	2008	53
Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice. Yoshio Honma, Yuki Ishii, Yuri Yamamoto-Yamaguchi, PubMed Trail Inhibited ApoptosisOncogenic AgentMedicineApoptosisImmunology	2003	51
Cytokinin-induced differentiation of human myeloid leukemia HL-60 cells is associated with the formation of nucleotides, but not with incorporation into DNA or RNA Yuki Ishii, Shingo Sakai, Yoshio Honma Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Hematological MalignancyChromatinDevelopmental BiologyCytokinin-induced DifferentiationGene Expression	2003	41
Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells Yuki Ishii, Takashi Kasukabe, Yoshio Honma Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ChromatinSignal TransductionCytokinin-induced DifferentiationSignaling PathwayCell Regulation	2005	33
Bortezomib Enhances the Efficacy of Fulvestrant by Amplifying the Aggregation of the Estrogen Receptor, Which Leads to a Proapoptotic Unfolded Protein Response Yuki Ishii, Luena Papa, Urvashi Bahadur, Clinical Cancer Research	2011	33
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells Kran Suknuntha, Yuki Ishii, Lihong Tao, Stem Cell Research	2015	32

Page 1